Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients

Evaluating the cost-effectiveness of [18F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients

Abstract Background A recent randomised trial demonstrated [18F]fluorodeoxyglucose positron-emission tomography in combination with low-dose CT (FDG-PET/CT), compared to standard of care computed tomography (CT) imaging, positively impacted antimicrobial management and outcomes of acute leukaemia an...

Full description

Bibliographic Details
Main Authors: Michelle Tew, Abby P. Douglas, Jeff Szer, Ashish Bajel, Simon J. Harrison, Shio Yen Tio, Leon J. Worth, Rodney J. Hicks, David Ritchie, Monica A. Slavin, Karin A. Thursky, Kim Dalziel
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Cancer Imaging
Subjects:
Cost-effectiveness
Costing
Diagnostic imaging
Febrile neutropenia
Antimicrobial
Online Access:https://doi.org/10.1186/s40644-023-00647-7

Internet

https://doi.org/10.1186/s40644-023-00647-7

Similar Items